Cancer stem cells: advances in knowledge and implications for cancer therapy

X Chu, W Tian, J Ning, G Xiao, Y Zhou… - … and Targeted Therapy, 2024 - nature.com
Cancer stem cells (CSCs), a small subset of cells in tumors that are characterized by self-
renewal and continuous proliferation, lead to tumorigenesis, metastasis, and maintain tumor …

Extracellular matrix and its therapeutic potential for cancer treatment

J Huang, L Zhang, D Wan, L Zhou, S Zheng… - … and Targeted Therapy, 2021 - nature.com
The extracellular matrix (ECM) is one of the major components of tumors that plays multiple
crucial roles, including mechanical support, modulation of the microenvironment, and a …

Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy

P Zheng, C Zhou, L Lu, B Liu, Y Ding - Journal of Experimental & Clinical …, 2022 - Springer
Elesclomol is an anticancer drug that targets mitochondrial metabolism. In the past,
elesclomol was recognized as an inducer of oxidative stress, but now it has also been found …

[HTML][HTML] Dysregulated FOXM1 signaling in the regulation of cancer stem cells

G Sher, T Masoodi, K Patil, S Akhtar… - Seminars in cancer …, 2022 - Elsevier
Since the introduction of the cancer stem cell (CSC) paradigm, significant advances have
been made in understanding the functional and biological plasticity of these elusive …

Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes

CM Beaufort, JCA Helmijr, AM Piskorz, M Hoogstraat… - PloS one, 2014 - journals.plos.org
Epithelial ovarian cancer is a highly heterogeneous disease and remains the most lethal
gynaecological malignancy in the Western world. Therapeutic approaches need to account …

The unique molecular and cellular microenvironment of ovarian cancer

T Worzfeld, E Pogge von Strandmann, M Huber… - Frontiers in …, 2017 - frontiersin.org
The reciprocal interplay of cancer cells and host cells is an indispensable prerequisite for
tumor growth and progression. Cells of both the innate and adaptive immune system, in …

Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells

U Testa, E Petrucci, L Pasquini, G Castelli, E Pelosi - Medicines, 2018 - mdpi.com
Four main histological subtypes of ovarian cancer exist: serous (the most frequent),
endometrioid, mucinous and clear cell; in each subtype, low and high grade. The large …

CD24: a novel target for cancer immunotherapy

E Panagiotou, NK Syrigos, A Charpidou… - Journal of Personalized …, 2022 - mdpi.com
Cluster of differentiation 24 (CD24) is a small, highly glycosylated cell adhesion protein that
is normally expressed by immune as well as epithelial, neural, and muscle cells. Tumor …

Targeting cancer stem cells to overcome chemoresistance

T Nunes, D Hamdan, C Leboeuf… - International journal of …, 2018 - mdpi.com
Cancers are heterogeneous at the cell level, and the mechanisms leading to cancer
heterogeneity could be clonal evolution or cancer stem cells. Cancer stem cells are resistant …

Cancer stem–like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production

T Hiraga, S Ito, H Nakamura - Cancer research, 2013 - AACR
CD44, an adhesion molecule that binds to the extracellular matrix, primarily to hyaluronan
(HA), has been implicated in cancer cell migration, invasion, and metastasis. CD44 has also …